|
Shoulder Reconstruction
|
Bertram Zarins, M.D. |
1990 |
N Engl J Med 1990; 323:555 |
Open
|
|
Hypertensive Heartbreak
|
Emily S. Lau, M.D., Anand Vaidya, M.D., Inga-Marie Schaefer, M.D., and Benjamin M. Scirica, M.D., M.P.H. |
2021 |
N Engl J Med 2021; 384:e80 |
Open
|
|
Hearing Music while Checking a Pulse
|
Leanna Wise, M.D. |
2020 |
N Engl J Med 2020; 383:e139 |
Open
|
|
Enoxaparin as Prophylaxis against Thromboembolism after Total Hip Replacement
|
|
1997 |
N Engl J Med 1997; 336:585-586 |
Open
|
|
Total Hip and Total Knee Replacement List of authors.
|
William H. Harris, M.D., and Clement B. Sledge, M.D. |
1990 |
N Engl J Med 1990; 323:801-807 |
Open
|
|
Prevention as Precipitant
|
Aaron W. Aday, M.D., Arturo P. Saavedra, M.D., Ph.D., Bruce D. Levy, M.D., and Joseph Loscalzo, M.D., Ph.D. |
2016 |
N Engl J Med 2016; 375:471-475 |
Open
|
|
Therapeutic Potential of Oral Factor Xa Inhibitors List of authors.
|
Elaine M. Hylek, M.D., M.P.H. |
2010 |
N Engl J Med 2010; 363:2559-2561 |
Open
|
|
Systemic Granulomatous Reaction to a Foreign Body after Hip Replacement
|
Michel Péoc'h, M.D. Christophe Moulin, M.D. Basile Pasquier, M.D. |
1996 |
N Engl J Med 1996; 335:133-134 |
Open
|
|
Hypertensive Heartbreak
|
Emily S. Lau, M.D., Benjamin Scirica, M.D., M.P.H., Inga-Marie Schaefer, M.D., Amy L. Miller, M.D., Ph.D., et al. |
2021 |
N Engl J Med 2021; 384:2145-2152 |
Open
|
|
Total Hip and Total Knee Replacement List of authors.
|
William H. Harris, M.D., and Clement B. Sledge, M.D. |
1990 |
N Engl J Med 1990; 323:725-731 |
Open
|
|
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
|
Bengt I. Eriksson, M.D., Ph.D., Lars C. Borris, M.D., Richard J. Friedman, M.D., Sylvia Haas, M.D., et al., for the RECORD1 Study Group* |
2008 |
N Engl J Med 2008; 358:2765-2775 |
Open
|
|
Minimally Invasive Total Knee Arthroplasty for Osteoarthritis
|
Seth S. Leopold, M.D. |
2009 |
N Engl J Med 2009; 360:1749-1758 |
Open
|
|
Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty
|
David Garcia, M.D. |
2018 |
N Engl J Med 2018; 378:762-763 |
Open
|
|
Infection Associated with Prosthetic Joints
|
Jose L. Del Pozo, M.D., Ph.D., and Robin Patel, M.D. |
2009 |
N Engl J Med 2009; 361:787-794 |
Open
|
|
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis List of authors.
|
Harry R. Büller, M.D., Claudette Bethune, Ph.D., Sanjay Bhanot, M.D., Ph.D., David Gailani, M.D., et al., for the FXI-ASO TKA Investigators* |
2015 |
N Engl J Med 2015; 372:232-240 |
Open
|
|
Differences between Men and Women in the Rate of Use of Hip and Knee Arthroplasty
|
Gillian A. Hawker, M.D., James G. Wright, M.D., M.P.H., Peter C. Coyte, Ph.D., J. Ivan Williams, Ph.D., et al. |
2000 |
N Engl J Med 2000; 342:1016-1022 |
Open
|
|
Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture
|
|
2020 |
N Engl J Med 2020; 382:1072-1074 |
Open
|
|
Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture List of authors.
|
|
2019 |
N Engl J Med 2019; 381:2199-2208 |
Open
|
|
Predictors of Rehospitalization for Symptomatic Venous Thromboembolism after Total Hip Arthroplasty
|
Richard H. White, M.D., Sharmeen Gettner, Ph.D., Jeffrey M. Newman, M.D., M.P.H., Kenneth B. Trauner, M.D., et al. |
2000 |
N Engl J Med 2000; 343:1758-1764 |
Open
|
|
Racial, Ethnic, and Geographic Disparities in Rates of Knee Arthroplasty among Medicare Patients
|
Jonathan Skinner, Ph.D., James N. Weinstein, D.O., Scott M. Sporer, M.D., and John E. Wennberg, M.D., M.P.H. |
2003 |
N Engl J Med 2003; 349:1350-1359 |
Open
|
|
Racial, Ethnic, and Geographic Disparities in Rates of Knee Arthroplasty
|
|
2004 |
N Engl J Med 2004; 350:305-306 |
Open
|
|
Should Total Hip Arthroplasty Be Used for Hip Fracture?
|
Jan-Erik Gjertsen, M.D., Ph.D. |
2019 |
N Engl J Med 2019; 381:2261-2262 |
Open
|
|
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
|
Michael R. Lassen, M.D., Walter Ageno, M.D., Lars C. Borris, M.D., Jay R. Lieberman, M.D., et al. |
2008 |
N Engl J Med 2008; 358:2776-2786 |
Open
|
|
Hip Arthroplasty
|
John M. Cuckler, M.D. |
1992 |
N Engl J Med 1992; 326:777 |
Open
|
|
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty
|
David R. Anderson, M.D., Michael Dunbar, M.D., John Murnaghan, M.D., Susan R. Kahn, M.D., et al. |
2018 |
N Engl J Med 2018; 378:699-707 |
Open
|